Product Details:
Minimum Order Quantity | 1 Bottle |
Drug Name | Tenofovir Alfenamide 25mg |
Indications | HBV infection |
Packaging Size | 1*30 |
Medicine Type | Allopathic |
Form Of Medicines | Tablets |
Dosage Form | Tablet |
Type of Medicines | Allopathic |
Packaging Type | Bottles |
Dose | As Per Doctor Prescription |
Company Name | Mylan |
Tenofovir alafenamide is used to treat chronic hepatitis B infection, a viral infection of the liver. It works by stopping or slowing the growth of the virus. Chronic hepatitis infection can lead to serious liver damage (cirrhosis) and liver cancer.
Before starting treatment with this medication, your doctor should test you for HIV infection. If you have HIV infection along with hepatitis B infection, Tenofovir alafenamide should not be used alone since this may make it harder to treat your HIV infection. Combination drug treatment should always be used to treat HIV infection.
Read the Patient Information Leaflet if available from your pharmacist before you start taking tenofovir alafenamide, and each time you get a refill. If you have any questions, ask your doctor or pharmacist.
Take this medication by mouth with food as directed by your doctor, usually once daily.
The dosage is based on your medical condition, response to treatment, and other medications you may be taking. Be sure to tell your doctor and pharmacist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products).
For the best effect, take this medication at evenly spaced times. To help you remember, take this medication at the same time every day.
Do not take more or less of this drug than prescribed or stop taking it even for a short time unless directed to do so by your doctor. Doing so may make the infection worse or harder to treat (resistant), or worsen side effects.
Side Effects:--
Headache, tiredness, dizziness, or cough may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly.
Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
Precautions:---
Before taking Tenofovir alafenamide, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
Before using this medication, tell your doctor or pharmacist your medical history, especially of: kidney problems, HIV infection, other liver problems (such as hepatitis C, cirrhosis), bone problems (such as bone disease, bone loss/osteoporosis, weak/broken bones), disease of the pancreas (pancreatitis).
Km Healthcare is exporter of Tenofovir alafenamide 25mg Tablet.
We are the trader, distributor, exporter of Hepbest Tablet.
Additional Information:
Product Details:
Brand | Tenvir |
Drug Name | Tenofovir Alfenamide 25mg |
Dose/Strength | 1 Tablet day |
Packaging Size | 1x30 |
Tenofovir alafenamide is used to treat chronic hepatitis B infection, a viral infection of the liver. It works by stopping or slowing the growth of the virus. Chronic hepatitis infection can lead to serious liver damage (cirrhosis) and liver cancer.
How to use Tenofovir Alafenamide Fumarate Tablet:---
Before starting treatment with this medication, your doctor should test you for HIV infection. If you have HIV infection along with hepatitis B infection, Tenofovir alafenamide should not be used alone since this may make it harder to treat your HIV infection. Combination drug treatment should always be used to treat HIV infection.
Read the Patient Information Leaflet if available from your pharmacist before you start taking tenofovir alafenamide, and each time you get a refill. If you have any questions, ask your doctor or pharmacist.
Take this medication by mouth with food as directed by your doctor, usually once daily.
The dosage is based on your medical condition, response to treatment, and other medications you may be taking. Be sure to tell your doctor and pharmacist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products).
For the best effect, take this medication at evenly spaced times. To help you remember, take this medication at the same time every day.
Do not take more or less of this drug than prescribed or stop taking it even for a short time unless directed to do so by your doctor. Doing so may make the infection worse or harder to treat (resistant), or worsen side effects.
Side Effects:--
Headache, tiredness, dizziness, or cough may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly.
Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
Precautions:---
Before taking Tenofovir alafenamide, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
Before using this medication, tell your doctor or pharmacist your medical history, especially of: kidney problems, HIV infection, other liver problems (such as hepatitis C, cirrhosis), bone problems (such as bone disease, bone loss/osteoporosis, weak/broken bones), disease of the pancreas (pancreatitis).
Km Healthcare is exporter of Tenofovir alafenamide 25mg Tablet.
We are the trader, distributor, exporter of Tafnat Tablet.
Product Details:
Packaging Size | 1*30 Tablet |
Packaging Type | Tablet |
Dose/Strength (ex. 1 mg or 1 ml) | Once a daily |
Usage | Hospital |
Product Details:
Minimum Order Quantity | 5 Bottle |
Dose/Strength | 0.5mg daily |
Packaging Size | 1x30 |
Product Details:
Minimum Order Quantity | 1 Bottle |
Brand | Tenvir |
Usage/Application | hepatitis |
Drug Name | tenofovir |
Packaging Size | 1*30 |
Packaging Type | 1*30 |
Dosage Form | Tablet |
Company Name | tenofovir,Natco. Mylans |
Hepbest 25mg
Company : Mylan Pharmaceutical
Contain : Tenofvir Alafenamide25mg
Packing : 1*30 Tabalet
Hepbest is marketed by Natco. Mylans'''' Tenofovir Alafenamide is available in india. Hepbest is generic of VEMLIDY tablet.
Tenofovir alafenamide is used to treat chronic hepatitis B infection, a viral infection of the liver. It works by stopping or slowing the growth of the virus. Chronic hepatitis infection can lead to serious liver damage (cirrhosis) and liver cancer.
Before starting treatment with this medication, your doctor should test you for HIV infection. If you have HIV infection along with hepatitis B infection, Tenofovir alafenamide should not be used alone since this may make it harder to treat your HIV infection. Combination drug treatment should always be used to treat HIV infection.
Read the Patient Information Leaflet if available from your pharmacist before you start taking tenofovir alafenamide, and each time you get a refill. If you have any questions, ask your doctor or pharmacist.
Take this medication by mouth with food as directed by your doctor, usually once daily.
The dosage is based on your medical condition, response to treatment, and other medications you may be taking. Be sure to tell your doctor and pharmacist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products).
For the best effect, take this medication at evenly spaced times. To help you remember, take this medication at the same time every day.
Do not take more or less of this drug than prescribed or stop taking it even for a short time unless directed to do so by your doctor. Doing so may make the infection worse or harder to treat (resistant), or worsen side effects.
Side Effects:--
Headache, tiredness, dizziness, or cough may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly.
Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
Precautions:---
Before taking Tenofovir alafenamide, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
Before using this medication, tell your doctor or pharmacist your medical history, especially of: kidney problems, HIV infection, other liver problems (such as hepatitis C, cirrhosis), bone problems (such as bone disease, bone loss/osteoporosis, weak/broken bones), disease of the pancreas (pancreatitis).
Km Healthcare is exporter of Tenofovir alafenamide 25mg Tablet.
We are the trader, distributor, exporter of Hepbest Tablet.
Product Details:
Minimum Order Quantity | 3 Bottle |
Brand | Myhep All |
Composition | Sofosbuvir 400mg And Velpatasvir 100mg |
Indications | HCV |
Dosage Form | Tablet |
Myhep All
Packing: 1*28 Tablet
Company: Mylan
Contain : Sofosbuir 400mg Velpatasvir 100mg
Velpanat by Natco contain Sofosbuvir 400mg and Velpatasvir 100mg . Velpanat is generic.
Natco''''s Velpanat is use for the treatment of Hepatitis C. Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.
The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:
# injecting drug use through the sharing of injection equipment;
# The reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and the transfusion of unscreened blood and blood products.
Velpanat contain Sofosbuvir Velpatasvir . Sofosbuvir is a HCV nucleotide analog NS5B polymerase inhibitor and Velpatasvir is hepatitis C virus NS5A inhibitor . Velpanat is indicated for the treatment of Chronic Hepatitis genotype 1,2,3,4,5,6 infection.
The Clinical trail (Astral Trail) was conducted. And the SVR after 12 week was studies in all HCV genotype patient. In the Genotype 1 patient without cirrhosis or with compensated cirrhosis SVR was 98 to 99%. In Genotype 2 patient SVR was found 99%, In Genotype 3 SVR was 95% And in genotype 4 and 6 SVR was 100% And 95% in Genotype 5.
In Decompensated Cirrhosis after 12week therapy Sofosbuvir + Velpatasvir in combination with Ribavarin SVR was found 94%.
SVR meaning no detectable of HCV virus after 12 week of treatment.
Dosage:
The recommended dose of Velpanat tablet once daily , taken orally, with or without food .
The recommended dose of Velpanat ( Sofosbuvir + Velpatasvir ) is as below. In Genotype 1,2,3,4,5,6 without cirrhosis And Patient with compensated cirrhosis is 12 weeks without Ribavarin.
The dose of Velpanat In Genotype 1,2,3,4,5,6 Patient with decompensated cirrhosis is 12 weeks with Ribavarin
Adverse Reaction:
Most common adverse reactions observed with Velpanat is headache , Fatigue , Asthenia , Nausia, Headache ,insomnia , diarrhea.
Storage : Velpnat should be stored below temperature 30°C.
Side Effect:
Most common side effect with Velpanat is tiredness , headache , weakness, confusion, memory problems ,
Velpanat should be taken on Doctor prescription only.
K M Healthcare is trader , exporter, supplier of Myhep All Tablet at very economical price.
Velpanat In India , Natco Velpanat , Natco’s Sofosbuvir and Velpatasavir.
Velpatasvir and Sofosbuvir supplier from India, Hpecinat Lp Supplier
We are Supplier Exporter of Velpanat to the patient and many country. We supply it to county like Russia, Romania, Ukraine, Belarus, Uzbekistan , Cambodia , Singapore,China , Minsk , Armenia , Europe Germany , London, Switzerland , France, Denmark, Barcelona, Spain, Austria, Australia, Africa , Newzeland , Vietnam , Hongkong, Japan, Australia , Afghanistan , Maldova , Iran, Dubai , Philippines, Thailand , Malaysia , Indonesia, Uk , London ,Germany and many more countries and Cities.
Product Details:
Packaging Type | 1*28 Tablet |
Indications | HCV |
Strength/Dose (in mg or ml) | 1 Tablet in a day. |
Pack Size | 1*28 |
Product Type | Finish Product |
Brand | Velasof |
Velasof Tablet
Packing: 1*28 Tablet
Company: Hetero
Contain : Sofosbuir 400mg Velpatasvir 100mg
Velasof Tablet by Hetero contain Sofosbuvir 400mg and Velpatasvir 100mg . Velasof Tablet is generic.
Hetero's Velasof Tablet is use for the treatment of Hepatitis C. Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.
Dosage:The recommended dose of Velasof Tablet tablet once daily , taken orally, with or without food .
The recommended dose of Velasof Tablet ( Sofosbuvir + Velpatasvir ) is as below.
Genotype 1,2,3,4,5,6 without cirrhosis And Patient with compensated cirrhosis is 12 weeks without Ribavarin.
The dose of Velasof Tablet In Genotype 1,2,3,4,5,6 Patient with decompensated cirrhosis is 12 weeks with Ribavarin
Adverse Reaction:
Most common adverse reactions observed with Velasof Tablet is headache , Fatigue , Asthenia , Nausea, Headache ,insomnia , diarrhea.
Storage : Velasof should be stored below temperature 30°C.
Side Effect:
Most common side effect with Velasof Tablet is tiredness , headache , weakness, confusion, memory problems ,
Velasof Tablet should be taken on Doctor prescription only.
K M Healthcare is trader , exporter, supplier of Velasof Tablet at very economical price.
Velasof Tablet In India , Hetero Velasof Tablet , Hetero’s Sofosbuvir and Velpatasavir.
Velpatasvir and Sofosbuvir supplier from India, Velasof exporter Supplier
K M Healthcare Supplier Exporter of Velasof Tablet to the patient and many country. We supply it to county like Russia, Romania, Ukraine, Belarus, Uzbekistan , Cambodia , Singapore,China , Minsk , Armenia , Europe Germany , London, Switzerland , France, Denmark, Barcelona, Spain, Austria, Australia, Africa , Newzeland , Vietnam , Hongkong, Japan, Australia , Afghanistan , Maldova , Iran, Dubai , Philippines, Thailand , Malaysia , Uk , London ,Germany and many more countries and Cities.
Product Details:
Minimum Order Quantity | 50 Box |
Packaging Size | 1*28 |
Dose/Strength (ex. 1 mg or 1 ml) | 400mg |
Usage | Clinical, Hospital, Personal |
Packaging Type | Tablet |
DaclaHep
Packing - 1*28 Tablet
Company - Hetro
contain - Daclatasvir
DaclaHep contain Daclatasvir 60mg . DaclaHep is for the treatment of Hepatitis C.
DaclaHep should be taken with doctor prescriptin only.
K M healthcare is trader or supplier of DaclaHep Tablet.
We supply the medicine on the doctor presription or to the medicine license holder only.
Sofosbuvir Is indicated for the treament fo Hepatitis C.
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130–150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.
The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:
injecting drug use through the sharing of injection equipment;
the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
the transfusion of unscreened blood and blood products.
Sofosbuvir should be used in combination with ribavirin or with pegylated interferon and ribavirin
Sofosbuvir is effective for the treatment of HCV in Genotyp 1 ,Genotype 2 ,Genotype 3 , Genotype 4.
Sofosbuvir and ribavirin therapy for 24 weeks can be considered for patients with genotype 1.
MyhepLvir Sofosbuvir + Ledipasvir show the cure rate of 95 to 97 % In Genotype 1 non Cirrhosis Patient. Myhep Lvir or can be used in thr treatment of HIV+HCV Coinfections.
Cure rate means there is no detection of HCV virus in the blood 3 month after treatment is complated.
In Clinical Studies Sofosbuvir and Valpatasvir Cure rates are 99 % In genotype 2 and 95% In Genotype 3 Patient.
In Genotype 1 and GT4 and GT5 MyhepAll show the cure rate of 97 to 100%
K M Healthcare is supplier of MYHEPALL, Myhep Lvir, Myhep , Ribavarin, Sofosbuvri & Daclastavir Combination or Sofosbuvir+ Ledipasvir Combination or Ipclusa Sofosbuvir + Valpatasvir Combnation.
We supply the medicine worldwide . We have client in India, Cambodia, Vietnam , Africa, Russia, China , UK , Europe, Canada , Belarus , Ukraine ,Tazakistan, Iran ,Latin America , Hongkong and many more country .
Product Details:
Dose | 400 mg |
Usage | Hospital |
Packaging Type | Tablets |
Product Type | Finished Product |
Packaging Size | 1*28 |
Dacla Hep is a generic Tablet.
We supply the medicine on the doctor prescription or to the medicine license holder only.
Generic of , Daclatasvir 60mg, Dacla Hpe Daclatasvir. Dacla Hep INDIA.
Product Details:
Packaging Size | 60mg |
Packaging Type | 1*28 Tablet |
Dose/Strength (ex. 1 mg or 1 ml) | 60 mg |
Usage | Personal |
Mydekla
Packing 1*28 Tablet
Contain : daclastavir 60mg
Company : Mylan
We supply the medicine on the doctor prescription or to the medicine license holder only.
Generic Daclastavir , Daclatasvir 60mg, Mylan Daclatasvir. My Dacla INDIA.
Product Details:
Packaging Size | *1*28 |
Packaging Type | Tablet |
Dose/Strength (ex. 1 mg or 1 ml) | Once in a Day |
Usage | Hospital |
Hepcdac :
Packing - 1*28 Tablet
Company - Cipla
contain - Daclatasvir
Hepcdac is marketed and Manufactured by Cipla Pharmaceuticals LTD. Hepcdac daclastavir is available as 60mg and 30 mg Tablet Packing of 28 Pills. Hepcdac is Generic of Deklinza Of BMS.
Hepcdac should be taken with doctor prescription only
Hepcdac is a hepatitis C virus (HCV) inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection.
Daclatasvir is an inhibitor of NS5A, a nonstructural protein encoded by HCV. Daclatasvir
binds to the N-terminus of NS5A and inhibits both viral RNA replication and virion assembly.
Dosage:
Hepcdac contain Daclatasvir 60mg . Hepcdac of Cipla is for the treatment of Hepatitis C.
The recommended dosage of Hepcdac is 60 mg, taken orally, once daily, with or without food .
For HCV genotype 1 or 3 patients with cirrhosis or post-transplantation patients, the starting dose of ribavirin is 600 mg once daily, increasing up to 1000 mg daily as tolerated. The starting dose and on-treatment dose of ribavirin can be decreased based on hemoglobin and creatinine clearance.
For HCV genotype 3 patients with compensated cirrhosis, the recommended dosing of ribavirin is based on weight 1000 mg for patients weighing less than 75 kg and 1200 mg for those weighing at least 75 kg administered orally in two divided doses with food
Adverse Reaction:
Most common adverse reactions observed with Hepcdac in combination with Hepcinat were headache and fatigue.
Most common adverse reactions observed with Daclastavir in combination with
sofosbuvir and ribavirin were headache, anemia, fatigue, and nausea.
Storage : Hepcdac should be stored at room temperature between 20°C and 25°C
Side Effects: Patient should contact to the physician if get the side effects on Daclatasvir treatment like Dizziness , not feeling well ,Tiredness, weakness, Chest Pain , Headache., Anemia,
K M healthcare is trader , Exporter or supplier of Hepcdac Daclastavir Tablet.
.
KM Healthcare supply Hepatitis C Medicines Daclastavir at very affordable price.
We export Daclastavir ( Hepcdac ) Tablet to Russia, China, Belarus, Kazakhstan, Ukraine, Georgia , Cambodia, Vietnam , China , Armenia , Belarus , Moldova , Tajakistan , Romania , Minsk ,Uzbekistan , Moscow , Kiev, African Countries, Afganiztan , Istambul, Uk , Germany , Hongkong , Iran , Itlay, and many more countries and cities.
Product Details:
Minimum Order Quantity | 1 Bottle |
Brand | Ledihep Tablet |
Drug Name | Sofosbuvir 400mg and Ledipasvir 90mg |
Packaging Type | Tablet |
Indications | HCV |
Packaging Size | 28 tAblet |
Usage | Clinical |
Dose/Strength (ex. 1 mg or 1 ml) | Once daily |
Ledihep Tablet
Packing: 1*28 Tablet
Company: Zydus
Contain : Sofosbuir 400mg Ledipasvir 90mg
Ledihep by Zydus contain Sofosbuvir 400mg and Ledipasvir 90mg
Zydus''s Ledihep is use for the treatment of Hepatitis C. Ledihep contain Sofosbuvir Ledipasvir . Sofosbuvir is a HCV nucleotide analog NS5B polymerase inhibitor and Ledipasvir is hepatitis C virus NS5A inhibitor . Ledihep is indicated for the treatment of Chronic Hepatitis genotype 1,4,5,6 infection.
Ledihep Sofosbuvir + Ledipasvir show the cure rate of 95 to 97 % In Genotype 1 non Cirrhosis Patient. Ledihep can be used in the treatment of HIV+HCV Co-infections.
Cure rate means there is no detection of HCV virus in the blood 3 month after treatment is completed.
In Clinical Studies Sofosbuvir and Valpatasvir Cure rates are 99 % In genotype 2 and 95% In Genotype 3 Patient.
In Genotype 1 and GT4 and GT5 MyhepAll show the cure rate of 97 to 100%
Dosage:
The recommended dose of Ledihep 400mg mg tablet once daily , taken orally, with or without food .
The recommended dose of Ledihep ( Sofosbuvir + Ledipasvir ) is as below.
In Genotype 1 treatment naive , with or without cirrhosis is 12 weeks .
In Genotype 1 treatment experienced without cirrhosis is 12 weeks.
In Genotype 1 treatment experienced without cirrhosis is 24 weeks.
For Genotype 4 5 6 treatment naive or experienced , with or without cirrhosis 12weeks.
Adverse Reaction:
Most common adverse reactions observed with Ledihep is headache , Fatigue , Asthenia.
Storage : Ledihep should be stored at room temperature between 30°C.
Side Effect:
Patient may might experience Slow heart rate on treatment.
Most common side effect with is tiredness , headache , weakness.
Ledihep should be taken on Doctor prescription only.
K M Healthcare is trader , exporter, supplier of Ledihep Tablet at very economical price.
Ledihep In India , Zydus Ledihep , Zydus’s Sofosbuvir and Ledipasvir,
Ledipasvir and Sofosbuvir supplier from India, Ledihep Supplier
We are Supplier Exporter of Ledihep to the patient and many country. We supply it to county like Russia, Romania, Ukraine, Belarus, Uzbekistan , Cambodia , China , Minsk , Armenia , Europe , Australia, Africa , Newzeland , Vietnam , Hongkong, Japan, Australia , Afganistan, Iran, Dubai , Philippines, Thailand , Malaysia , Uk , London ,Germany .
Additional Information:
Product Details:
Minimum Order Quantity | 1 Bottle |
Brand | Myhep Lvir |
Composition | sofosbuvir 400mg and Ledipasvir ,sofosbuvir 400mg and Ledipasvir 90mg |
Packaging Size | 1*28 |
Packaging Type | bottle |
Indications | HCV |
Dosage Form | Tablet |
MyHep LVIR Tablet
Packing: 1*28 Tablet
Company: Mylan
Contain : Sofosbuir 400mg & Ledipasvir 90mg
Myhep LVIR by Mylan contain Sofosbuvir 400mg and Ledipasvir 90mg .
MYHEP LVIR is use for the treatment of Hepatitis C.
MYHEP LVIR should be taken on Doctor prescription only.
K M Healthcare is trader and supplier of MYHEP LVIR Tablet at very economical price.
MYHEP LVIR In India , MYELAN MYHEPLVIR , MYLAN''s Sofosbuvir and Ledipasvir,
Ledipasvir and Sofosbuvir supplier from India, MYHEP LVIR Supplier.
We are supplier of Myhep Lvir To russia ,china, Cambodia, Vietnam , Belarus , Ukraine , Romania, afganistan, Iran, African Country and many more country.
Sofosbuvir Is indicated for the treament fo Hepatitis C.
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130–150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.
The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:
injecting drug use through the sharing of injection equipment;
the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
the transfusion of unscreened blood and blood products.
Sofosbuvir should be used in combination with ribavirin or with pegylated interferon and ribavirin
Sofosbuvir is effective for the treatment of HCV in Genotyp 1 ,Genotype 2 ,Genotype 3 , Genotype 4.
Sofosbuvir and ribavirin therapy for 24 weeks can be considered for patients with genotype 1.
MyhepLvir Sofosbuvir + Ledipasvir show the cure rate of 95 to 97 % In Genotype 1 non Cirrhosis Patient. Myhep Lvir or can be used in thr treatment of HIV+HCV Coinfections.
Cure rate means there is no detection of HCV virus in the blood 3 month after treatment is complated.
In Clinical Studies Sofosbuvir and Valpatasvir Cure rates are 99 % In genotype 2 and 95% In Genotype 3 Patient.
In Genotype 1 and GT4 and GT5 MyhepAll show the cure rate of 97 to 100%
K M Healthcare is supplier of MYHEPALL, Myhep Lvir, Myhep , Ribavarin, Sofosbuvri & Daclastavir Combination or Sofosbuvir+ Ledipasvir Combination or Ipclusa Sofosbuvir + Valpatasvir Combnation.
We supply the medicine worldwide . We have client in India, Cambodia, Vietnam , Africa, Russia, China , UK , Europe, Canada , Belarus , Ukraine ,Tazakistan, Iran ,Latin America , Hongkong and many more country .
Product Details:
Minimum Order Quantity | 1 Unit |
Brand | Velpatasvir Tablet |
Drug Name | Velpatasvir |
Packaging Size | 1*28 |
Packaging Type | Tablet |
Indications | HCV |
Strength/Dose (in mg or ml) | 1 tablet in a day |
Pack Size | 1*28 |
Product Type | Finish Product |
Dosage Form | Tablet |
The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:
Product Details:
Minimum Order Quantity | 200 Box |
Packaging Size | 1*28 |
Packaging Type | Tablet |
Dose/Strength (ex. 1 mg or 1 ml) | 60 ,mg |
Usage | Hospital |
Additional Information:
Mydacla is a generic Tablet.
We supply the medicine on the doctor prescription or to the medicine license holder only.
Generic of , Daclatasvir 60mg, Mylan Daclatasvir. MyDacla INDIA.
Additional Information:
Additional Information:
Product Details:
Minimum Order Quantity | 20 Pack |
Strength/Dose (in mg or ml) | 400mg |
Pack Size | 28 tablet |
Product Type | Finish Product |
The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:
Product Details:
Minimum Order Quantity | 1 Bottle |
Pack Size | 1*28 |
Pack Type | Tablet |
We are supplier of Myhep to russia ,china, Cambodia, Vietnam , Belarus , Ukraine , Romania, afganistan, Iran, African Country and many more country.
Product Details:
Form | Injection |
Country of Origin | Made in India |
Product Details:
Pack Size | 1*28 |
Strength/Dose (in mg or ml) | Once Daily |
Product Type | Finish Product |
Hepcvir
Packing - 1*28 Tablet
Company – Cipla
contain - Sofosbuvir
Hepcvir is marketed and Manufactured by Gilead Cipla. Hepcivir contain Sofosbuvir 400mg .
Sofosbuvir Is indicated for the treament fo Hepatitis C. Hepcivir also can be use for the treatment of HCV HIV coinfections. Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
The hepatitis C virus is a blood borne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130–150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.
The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:
# injecting drug use through the sharing of injection equipment;
# The reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and the transfusion of unscreened blood and blood products.
Hepcivir Sofosbuvir should be used in combination with ribavirin , Daclastavir, or with pegylated interferon
Sofosbuvir is effective for the treatment of HCV in Genotyp 1 ,Genotype 2 ,Genotype 3 , Genotype 4.
Sofosbuvir and ribavirin therapy for 24 weeks can be considered for patients with genotype 1
HEPCIVIR is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor
Natdac is a hepatitis C virus (HCV) inhibitor indicated for use with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection.
Dosage:
The recommended dose of HEPCIVIR 400mg mg tablet once daily , taken orally, with or without food . Ribavarin dose is for the patient less then or equal to 75 kg is 1000mg and more then or equal to 75 kg is 1200mg.
Hepcivir in combination with ribavarin for 24weeks can be given to the Genotype 1 Patient who are interferone ineligible.
For genotype 2 patient treatment -naive and treatment experienced without cirrhosis or with compensated cirrhosis Hepcivir And Ribavarin should be gibven for 12 weeks
In Genotype 3 patient Treatment naive and treatment experienced without cirrhosis or with compensated cirrhosis Sofosbuvir and Ribavarin should be given for 24 weeks
Adverse Reaction:
Most common adverse reactions observed with Sofosbuvir in combination with Ribavarin is headache and fatigue.
Storage : Hepcivir should be stored at room temperature between 20°C and 25°C
Side Effect:
The black box warning of Hepcivir is Hepatitis B virus reactivation . Hepatitis B Virus could become active again during or after HCV treatment with Hepcivir.
K M healthcare is trader , Exporter or supplier of Hepcivir Sofosbuvir Tablet. .
KM Healthcare supply Hepatitis C Medicines Hepivir, Hepcinat, Hepcinat Lp , Myhep, Myhep Lvir at very affordable price.
We export of Sofosbuvir Tablet to Russia, China, Belarus, Kazakhstan, Ukraine, Georgia , Cambodia, Vietnam , China , Armenia , Belarus , Moldova , Tajakistan , Romania , Minsk ,Uzbekistan , Moscow , Kiev, African Countries, Afganiztan , Istambul, Uk , Germany , Hongkong , Iran , Itlay, and many more countries and cities.
Additional Information:
Additional Information:
Additional Information:
Packing: 1*28 Tablet
Company: Natco
Contain : Sofosbuir 400mg Velpatasvir 100mg
Velpanat by Natco contain Sofosbuvir 400mg and Velpatasvir 100mg . Velpanat is generic.
Natco's Velpanat is use for the treatment of Hepatitis C. Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.
The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:
# injecting drug use through the sharing of injection equipment;
# The reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and the transfusion of unscreened blood and blood products.
Velpanat contain Sofosbuvir Velpatasvir . Sofosbuvir is a HCV nucleotide analog NS5B polymerase inhibitor and Velpatasvir is hepatitis C virus NS5A inhibitor . Velpanat is indicated for the treatment of Chronic Hepatitis genotype 1,2,3,4,5,6 infection.
The Clinical trail (Astral Trail) was conducted. And the SVR after 12 week was studies in all HCV genotype patient. In the Genotype 1 patient without cirrhosis or with compensated cirrhosis SVR was 98 to 99%. In Genotype 2 patient SVR was found 99%, In Genotype 3 SVR was 95% And in genotype 4 and 6 SVR was 100% And 95% in Genotype 5.
In Decompensated Cirrhosis after 12week therapy Sofosbuvir + Velpatasvir in combination with Ribavarin SVR was found 94%.
SVR meaning no detectable of HCV virus after 12 week of treatment.
Dosage:
The recommended dose of Velpanat tablet once daily , taken orally, with or without food .
The recommended dose of Velpanat ( Sofosbuvir + Velpatasvir ) is as below. In Genotype 1,2,3,4,5,6 without cirrhosis And Patient with compensated cirrhosis is 12 weeks without Ribavarin.
The dose of Velpanat In Genotype 1,2,3,4,5,6 Patient with decompensated cirrhosis is 12 weeks with Ribavarin
Adverse Reaction:
Most common adverse reactions observed with Velpanat is headache , Fatigue , Asthenia , Nausia, Headache ,insomnia , diarrhea.
Storage : Velpnat should be stored below temperature 30°C.
Side Effect:
Most common side effect with Velpanat is tiredness , headache , weakness, confusion, memory problems ,
Velpanat should be taken on Doctor prescription only.
K M Healthcare is trader , exporter, supplier of Velpanat Tablet at very economical price.
Velpanat In India , Natco Velpanat , Natco’s Sofosbuvir and Velpatasavir.
Velpatasvir and Sofosbuvir supplier from India, Hpecinat Lp Supplier
We are Supplier Exporter of Velpanat to the patient and many country. We supply it to county like Russia, Romania, Ukraine, Belarus, Uzbekistan , Cambodia , Singapore,China , Minsk , Armenia , Europe Germany , London, Switzerland , France, Denmark, Barcelona, Spain, Austria, Australia, Africa , Newzeland , Vietnam , Hongkong, Japan, Australia , Afghanistan , Maldova , Iran, Dubai , Philippines, Thailand , Malaysia , Indonesia, Uk , London ,Germany and many more countries and Cities.
Additional Information:
Product Details:
Minimum Order Quantity | 1 Bottle |
Brand | Ledviclear |
Indications | HCV |
Usage | Personal |
The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:
Product Details:
Minimum Order Quantity | 100 Pack |
Pack Size | 1*28 |
Pack Type | Tablet |
Dose/Strength (mg or ml) | 400 mg |
The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:
Product Details:
Pack Type | Bottle |
Pack Size | 1*28 |
Dose/Strength (mg or ml) | 400mg |
The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:
Additional Information:
Product Details:
Packaging Size | 100 tablet |
Brand Name | Inramed |
Product Details:
Brand | Hepcvel |
Strength/Dose (in mg or ml) | Once Daily |
Pack Size | 1*28 |
Product Type | Finish Product |
Hepcvel Tablet
Packing: 1*28 Tablet
Company: Cipla
Contain : Sofosbuir 400mg Velpatasvir 100mg
Hepcvel Tablet by Cipla contain Sofosbuvir 400mg and Velpatasvir 100mg . Hepcvel Tablet is generic.
Hepcvel of Natco Tablet is use for the treatment of Hepatitis C. Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.
Dosage:
The recommended dose of Velasof Tablet tablet once daily , taken orally, with or without food .
The recommended dose of Velasof Tablet ( Sofosbuvir + Velpatasvir ) is as below.
Genotype 1,2,3,4,5,6 without cirrhosis And Patient with compensated cirrhosis is 12 weeks without Ribavarin.
The dose of Hepcvel Tablet In Genotype 1,2,3,4,5,6 Patient with decompensated cirrhosis is 12 weeks with Ribavarin
Adverse Reaction:
Most common adverse reactions observed with Velasof Tablet is headache , Fatigue , Asthenia , Nausea, Headache ,insomnia , diarrhea.
Storage : Velasof should be stored below temperature 30°C.
Side Effect:
Most common side effect with HepcvelTablet is tiredness , headache , weakness, confusion, memory problems ,
Hepcvel Tablet should be taken on Doctor prescription only.
K M Healthcare is trader , exporter, supplier of Velasof Tablet at very economical price.
Hepcvel Tablet In India , Hetero Velasof Tablet , Hetero’s Sofosbuvir and Velpatasavir.
Velpatasvir and Sofosbuvir supplier from India, Velasof exporter Supplier
K M Healthcare Supplier Exporter of Hepcvel Tablet to the patient and many country. We supply it to county like Russia, Romania, Ukraine, Belarus, Uzbekistan , Cambodia , Singapore,China , Minsk , Armenia , Europe Germany , London, Switzerland , France, Denmark, Barcelona, Spain, Austria, Australia, Africa , Newzeland , Vietnam , Hongkong, Japan, Australia , Afghanistan , Maldova , Iran, Dubai , Philippines, Thailand , Malaysia , Uk , London ,Germany and many more countries and Cities.
Product Details:
Country of Origin | Made in India |
Product Details:
Minimum Order Quantity | 1 Box |
Brand | Entavir 1 |